Joshua Kantrowitz

Director, The Director of the Columbia Schizophrenia Research Center (CSRC), New York State Psychiatric Institute · New York Presbyterian Hospital

Credentials: · · · ·

History

Columbia Schizophrenia Research Center · New York State Psychiatric Institute
Present
New York Presbyterian Hospital · Columbia University Department of Psychiatry
Present

Glutamatergic Mechanisms of Psychosis and Target Engagement
National Institute of Mental Health · R01
Contact PI · $2.9M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2020–2028
D-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia
National Institute of Mental Health · R33
Contact PI · $1.4M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2019–2028
Decoded fMRI Neurofeedback for Auditory Verbal Hallucinations in Schizophrenia
National Institute of Mental Health · R61
PI · $1.5M · Columbia University Health Sciences
2026–2028
D-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia
National Institute of Mental Health · R61
Contact PI · $1.2M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
2019–2021

A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia
Principal investigator · Recruiting · Phase 1, Phase 2
New York State Psychiatric Institute
2026–2027
Glutamatergic Mechanisms: Aim2
Principal investigator · Recruiting · Phase 1
New York State Psychiatric Institute
2022–2029
D-serine and Cognitive Remediation in Schizophrenia
Principal investigator · Completed · Phase 2
Nathan Kline Institute for Psychiatric Research
2014–2015
NMDA Antagonists in Bipolar Depression
Principal investigator · Completed · Phase 4
New York State Psychiatric Institute
2013–2016